Skip to main content

Table 1 Clinical and demographic data of the baseline population

From: Quality indicators in type 2 diabetes patient care: analysis per care-complexity level

  ESF UBS Tertiary health care P
(N = 148) (N = 148) (N = 192)
Sex (% female) 95 (64.2a) 93 (62.8b) 92 (47.9b) 0.003
Skin color (% white) 133 (89.9) 139 (93.9) 167 (87.0) 0.11
Age (years)1 68.5a ± 10.4 68.0a ± 10.6 63.5b ± 10.2 < 0.001
Education (% complete secondary school)2 53 (37.6a) 13 (46.4a) 39 (22.2b) 0.002
Occupation (% active) 30 (22.4a) 11 (45.8b) 65 (38.7b) 0.004
HbA1c  %2 7.60a ± 1.7 7.9a ± 1.8 8.6b ± 2.0 < 0.001
Hypertension, n (%)2 127 (85.8ab) 117 (79.1b) 178 (92.7a) 0.001
Dyslipidemia, n (%) 102 (68.9) 96 (64.9) 140 (72.9) 0.28
Depression, n (%) 30 (20.3) 26 (17.6) 36 (18.8) 0.84
Diabetes complications, n (%)2 25 (16.9a) 19 (12.8a) 110 (57.3b) < 0.001
Statin, n (%) 102 (68.9) 87 (58.8) 134 (69.8) 0.08
Metformin, n (%) 127 (85.8a) 128 (86.5a) 144 (75.0b) 0.009
NPH insulin, n (%) 31 (20.9a) 25 (16.9a) 128 (66.7b) < 0.001
Regular insulin, n (%) 2 (1.4a) 3 (2.0a) 50 (26.0b) < 0.001
  1. Data are shown as n (%) or mean and standard deviation
  2. ESF Estratégia de Saúde da Família (Family Health Strategy), UBS Unidade Básica de Saúde (Basic Health Care Unit)
  3. 1—a,b,cRepresent statistically different means
  4. 2—a,b,cRepresent statistically different proportions